tiprankstipranks
Blurbs

Nanosonics Limited (NNCSF) Receives a Sell from Goldman Sachs

Goldman Sachs analyst Chris Cooper maintained a Sell rating on Nanosonics Limited (NNCSFResearch Report) on August 23 and set a price target of A$3.40. The company’s shares closed yesterday at $2.91.

Cooper covers the Healthcare sector, focusing on stocks such as Pro Medicus Limited, Nanosonics Limited, and Cochlear Limited. According to TipRanks, Cooper has an average return of 4.5% and a 60.00% success rate on recommended stocks.

In addition to Goldman Sachs, Nanosonics Limited also received a Sell from J.P. Morgan’s David Low in a report issued yesterday. However, on August 22, Canaccord Genuity maintained a Buy rating on Nanosonics Limited (Other OTC: NNCSF).

See today’s best-performing stocks on TipRanks >>

Based on Nanosonics Limited’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $0. In comparison, last year the company had a net profit of $0

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Nanosonics Ltd is an Australia based healthcare equipment manufacturing company. It manufactures and distributes the trophon EPR ultrasound probe disinfector, which reduces the risk of ultrasound-related cross-infection. It also manufactures the associated consumables and accessories such as the trophon wall mount, trophon printer, trophon cart, trophon curved probe positioner and others. In addition, the company manufactures and commercializes infection control and decontamination products and services and related technologies. The entity operates in Australia and other countries, of which key revenue is derived from North America.

Read More on NNCSF:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles